11 results
·
18ms
·
Sources: EU EUDAMED, US FDA
KRR GLOVE, PATIENT EXAMINATION GLOVES
FDA 510(k)
FDA Class 1
·General Hospital
MANNITOL SALT AGAR
FDA 510(k)
FDA Class 1
·Microbiology
DELFIA(TM) TRIIODOTHYRONINE (T3) KIT
FDA 510(k)
FDA Class 2
·Clinical Chemistry
CADD MEDICATION CASSETTE RESERVOIRS
FDA Adverse Event
Malfunction
·ST PAUL·Product code FPA·August 6, 2020
CADD
FDA Adverse Event
Malfunction
·ST PAUL·Product code FPA·June 26, 2020
SYMBIQ SINGLE CHANNEL
FDA Adverse Event
Malfunction
·HOSPIRA COSTA RICA LTD.·Product code FRN·April 25, 2014
PRECISION®
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·January 3, 2013
UNKNOWN
FDA Adverse Event
Injury
·CPI - DEL CARIBE·Product code LWS·November 9, 2010
GXL acetabular liners, orthopedic hip implant component. Product Line Numbers: a. NOVATION CONSTRAINED LINER 28MM ID GROUP 1, REF 134-28-41 b. NOVATION CONSTRAINED LINER 32MM ID GROUP 2, REF 134-32-42 c. NOVATION CONSTRAINED LINER 36MM ID GROUP 3, REF 134-36-43 d. NOVATION CONSTRAINED LINER 36MM ID GROUP 4, REF 134-36-44 e. NOVATION CONSTRAINED LINER 36MM ID GROUP 5, REF 134-36-45
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·September 21, 2022
PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017
PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017